2 QLS Endorsed Courses | CPD Certified | Free PDF & Hard Copy QLS Certificates | 180 CPD Points | Lifetime Access
This module addresses characteristic issues influencing the registration of medicinal products based on monoclonal antibodies (mAbs), for use in humans. Regulatory requirements for the registration of biological medicinal products such as those based on mAbs differ in certain respects from those for small-molecule products. This is because of the distinct characteristics of biologics, such as complex structure and susceptibility to variation during manufacture.